ロード中...
Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients
BACKGROUND: Suppressor of cytokine signaling (SOCS) 1 and 3 methylation have been associated with clinical features and outcomes of cancer patients. However, their roles in determining the treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) re...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5438677/ https://ncbi.nlm.nih.gov/pubmed/28404963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16157 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|